Mednax Inc
$ 21.07
-1.86%
12 Feb - close price
- Market Cap 1,834,864,000 USD
- Current Price $ 21.07
- High / Low $ 21.50 / 20.80
- Stock P/E 11.03
- Book Value 10.59
- EPS 1.91
- Next Earning Report 2026-02-19
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.20 %
- 52 Week High 24.99
- 52 Week Low 11.84
About
MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.
Analyst Target Price
$22.67
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-08-05 | 2025-05-05 | 2025-02-18 | 2024-11-01 | 2024-08-06 | 2024-05-07 | 2024-02-20 | 2023-11-02 | 2023-08-03 | 2023-05-02 | 2023-02-17 |
| Reported EPS | 0.67 | 0.53 | 0.2427 | 0.51 | 0.44 | 0.34 | 0.2 | 0.32 | 0.32 | 0.39 | 0.23 | 0.47 |
| Estimated EPS | 0.4379 | 0.42 | 0.2646 | 0.3646 | 0.37 | 0.31 | 0.19 | 0.33 | 0.43 | 0.4 | 0.23 | 0.48 |
| Surprise | 0.2321 | 0.11 | -0.0219 | 0.1454 | 0.07 | 0.03 | 0.01 | -0.01 | -0.11 | -0.01 | 0 | -0.01 |
| Surprise Percentage | 53.003% | 26.1905% | -8.2766% | 39.8793% | 18.9189% | 9.6774% | 5.2632% | -3.0303% | -25.5814% | -2.5% | 0% | -2.0833% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.5 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MD
2026-02-12 17:27:46
Pediatrix Medical Group, Inc. (NYSE:MD) has received a consensus "Hold" rating from analysts, with five recommending a hold and one a buy. The average 12-month target price for the stock is $21.00. Recent insider selling by Director Michael Rucker and CEO Mark Ordan was noted, while institutional investors like Royal Bank of Canada and UBS AM have adjusted their positions in the company.
2026-02-12 08:28:39
Allianz Asset Management GmbH significantly increased its stake in Pediatrix Medical Group, Inc. by 158.5% in the third quarter, bringing its total holdings to 158,777 shares valued at $2.66 million. Other institutional investors like Ameriprise Financial Inc. and American Century Companies Inc. also raised their positions, with insider selling noted from Director Michael A. Rucker and CEO Mark S. Ordan. The company currently holds an average analyst rating of "Hold" with an average target price of $21.00.
2026-02-10 04:28:15
Pediatrix Medical Group (NYSE: MD) will host an investor conference call and webcast on Thursday, February 19, 2026, at 9:00 a.m. ET to discuss its fourth-quarter 2025 financial results. A detailed press release will precede the call on the same day. The webcast will be accessible through the company's investor relations website.
2026-02-09 14:28:47
Pediatrix Medical Group (MD) will host an investor conference call on February 19, 2026, at 9:00 a.m. ET to discuss its operational results for the quarter ended December 31, 2025. The call will be webcasted via the company's website and will provide crucial financial and operational insights. Analysts currently forecast a 1-year average price target of $23.50 for MD, with a "Moderate Buy" consensus based on recent upgrades.
2026-02-09 14:28:47
New York State Common Retirement Fund significantly increased its stake in Pediatrix Medical Group, Inc. by 87.9%, purchasing an additional 54,705 shares to bring its total holdings to 116,950 shares, valued at approximately $1.96 million. This move represents 0.13% ownership of the company, even as company insiders, including CEO Mark S. Ordan and Director Michael A. Rucker, have been selling shares. Analysts currently have an average "Hold" rating on Pediatrix Medical Group, with a consensus price target of $21.00.
2026-02-09 11:58:31
Pediatrix Medical Group (NYSE: MD) will host an investor conference call and webcast on February 19, 2026, at 9:00 a.m. ET to discuss its fourth-quarter 2025 financial results. A detailed press release will be issued that morning before market open. The webcast will be accessible via the company's investor relations website, www.pediatrix.com/investors.
